1.2400
27-11月-24 16:45:00
15 分の遅延
株式
+0.1300
+11.71%
本日の幅
1.1300 - 1.3600
ISIN
N/A
ソース
NASDAQ
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
17 2 2021 07:30:00 提供 Nasdaq GlobeNewswire
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference
19 1 2021 07:00:00 提供 Nasdaq GlobeNewswire